Navigation Links
CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied
Date:1/26/2009

New Research Illustrates Strong Health and Economic Benefits of OTC Heartburn Remedies

WASHINGTON, Jan. 26 /PRNewswire-USNewswire/ -- New research from the Consumer Healthcare Products Association (CHPA) and The Nielsen Company indicates 94 percent patient satisfaction with available over-the-counter (OTC) heartburn medications and estimates that OTC therapy saves patients an average total of $174 each in office visits and medication costs annually. In addition, CHPA and Nielsen attribute $757 million in annual savings to the U.S. healthcare system based on fewer office visits -- all good news for millions(1) of Americans who suffer from heartburn as well as an overburdened healthcare system.

"This is wonderful news for consumers. This study points to a high level of satisfaction plus costs savings among those who turn to OTC heartburn medicines for symptom relief," said Linda Suydam, president, CHPA. "The overall findings reflect the evolution of heartburn treatments as the availability of effective over-the-counter treatment options have expanded over the past 15 years."

"The savings these OTC medicines provide to the U.S. healthcare system are equally significant," said Jim Mansfield, The Nielsen Company and one of the study's authors. "Ongoing research into health outcomes and the cost of lost work time and misdiagnosis holds the potential to identify additional -- yet substantial -- savings."

CHPA and Nielsen's research also finds that more than half (61 percent) of consumers surveyed treat heartburn without discussing symptoms with a healthcare provider, and notes the importance of consumer education to safe and effective treatment.

"As with any OTC medication, consumers should read the label and follow directions closely to understand what the medicine is used for, to ensure appropriate dosing, and to avoid dangerous drug interactions," noted Janet P. Engle, Pharm.D., FAPhA, executive associate dean, professor and head, Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy. "Should they have any questions, it is important that they talk to their pharmacist. Severe or ongoing symptoms should be reported to a healthcare provider."

About the Study

The study, "Benefits of Over-the-Counter Heartburn Medication to Consumers and the Healthcare System" was conducted in 2008 and is based on online and written survey responses from nearly 10,000 U.S. consumers who use OTC heartburn medication.

The research was conducted using NielsenHealth's Upper GI Ailment Panel data related to consumer satisfaction with the full range of over-the-counter (OTC) heartburn remedies, including antacids, H2-blockers, and proton pump inhibitors (PPIs). Researchers used a combination of consumer data compiled by Nielsen and provider data compiled by WoltersKluwer Health's Dynamic Claims to estimate cost savings.

The report is available online (http://www.chpa-info.org/media/resources/r_5333.pdf).

About The Nielsen Company

The Nielsen Company is a global information and media company with leading marketing and consumer information, television and other media measurement, online intelligence, mobile measurement, trade shows and business publications (Billboard, The Hollywood Reporter, Adweek). The privately held company is active in more than 100 countries, with headquarters in New York, USA. For more information, please visit, www.nielsen.com.

About CHPA

CHPA is the 128-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements and is committed to promoting the increasingly vital role of healthcare remedies in America's healthcare system through science, education, and advocacy. For more information, please visit www.chpa-info.org.

(1) WebMD estimates one in 10 people suffer from heartburn symptoms each week.


'/>"/>
SOURCE Consumer Healthcare Products Association; The Nielsen Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
2. First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers
3. AUDIO from Medialink and Prilosec OTC: Recipes for Heartburn-Friendly Super Bowl Snacking
4. FDA Confirms No Heart Risk From Heartburn Drugs
5. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
6. Heartburn Can Be a Sign of Serious Disease
7. Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2
8. How chemotherapy drugs block blood vessel growth, slow cancer spread
9. B. Braun Medical Inc. Launches Home Infusion Therapy Web Site
10. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
11. Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick Care, a ... hours a day, Quick Care provides patients with the option to request and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... opioid overdose deaths now claim the lives of 62 Americans each day.(1) Yet ... against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... Boston, MA (PRWEB) , ... April 24, 2017 ... ... the cardiovascular health of individuals with HIV because it is not known to ... statins may have favorable effects to both lower cholesterol levels and dampen inflammation ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Urology, Uro/Gyn and Gynecology markets with innovative and ... joined the Company as Senior Vice President, Marketing ... Mr. Keswani will report directly to Darin ... organization is delighted that Ash has joined the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: